177 related articles for article (PubMed ID: 1734894)
21. The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type.
Heller M; Sukopp M; Tsomaia N; John M; Mierke DF; Reif B; Kessler H
J Am Chem Soc; 2006 Oct; 128(42):13806-14. PubMed ID: 17044709
[TBL] [Abstract][Full Text] [Related]
22. Solvent effects on the conformation of cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu-). An NMR spectroscopy and molecular modeling study.
Gonnella NC; Zhang X; Jin Y; Prakash O; Paris CG; Kolossváry I; Guida WC; Bohacek RS; Vlattas I; Sytwu T
Int J Pept Protein Res; 1994 May; 43(5):454-62. PubMed ID: 8070969
[TBL] [Abstract][Full Text] [Related]
23. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
[TBL] [Abstract][Full Text] [Related]
24. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 1H- and 13C-nuclear magnetic resonance spectroscopy, and its enantioface-differentiating ability.
Ishizu T; Fujii A; Noguchi S
Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):235-8. PubMed ID: 8500196
[TBL] [Abstract][Full Text] [Related]
25. The design of a specific ligand of HIV gp120.
Scarselli M; Facchiano A; Russo G; Molinari H; Ragona L; Zetta L; Niccolai N
J Pept Sci; 1997; 3(5):383-90. PubMed ID: 9391913
[TBL] [Abstract][Full Text] [Related]
26. Heterodetic bicyclic decapeptide cyclo (Glu1-Leu2-Pro3-Gly4-Ser5-Ile6-Pro7- Ala8) cyclo-(1 gamma-5 beta) Phe9-Gly10. Synthesis and 2-D NMR conformational analysis.
Barbato G; D'Auria G; Paolillo L; Zanotti G
Int J Pept Protein Res; 1991 May; 37(5):388-98. PubMed ID: 1917294
[TBL] [Abstract][Full Text] [Related]
27. Conformations of psi [CH2NH] pseudopeptides. Cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro]-TFA and cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro].
Ma S; Spatola AF
Int J Pept Protein Res; 1993 Feb; 41(2):204-6. PubMed ID: 8458694
[TBL] [Abstract][Full Text] [Related]
28. Conformational studies of cyclic peptide structures in solution from 1H-Nmr data by distance geometry calculation and restrained energy minimization.
Senn H; Loosli HR; Sanner M; Braun W
Biopolymers; 1990 Aug 15-Sep; 29(10-11):1387-400. PubMed ID: 2361151
[TBL] [Abstract][Full Text] [Related]
29. Conformations of cyclic pentapeptide endothelin receptor antagonists.
Bean JW; Peishoff CE; Kopple KD
Int J Pept Protein Res; 1994 Sep; 44(3):223-32. PubMed ID: 7822098
[TBL] [Abstract][Full Text] [Related]
30. Conformational preference for segetalins G and H, cyclic peptides with estrogen-like activity from seeds of Vaccaria segetalis.
Morita H; Yun YS; Takeya K; Itokawa H
Bioorg Med Chem; 1997 Nov; 5(11):2063-7. PubMed ID: 9416423
[TBL] [Abstract][Full Text] [Related]
31. Characterisation of the solution conformation of a cyclic RGD peptide analogue by NMR spectroscopy allied with a genetic algorithm approach and constrained molecular dynamics.
Sanderson PN; Glen RC; Payne AW; Hudson BD; Heide C; Tranter GE; Doyle PM; Harris CJ
Int J Pept Protein Res; 1994 Jun; 43(6):588-96. PubMed ID: 7928090
[TBL] [Abstract][Full Text] [Related]
32. Solution structure of endothelin B receptor selective antagonist RES-701-1 determined by 1H NMR spectroscopy.
Katahira R; Shibata K; Yamasaki M; Matsuda Y; Yoshida M
Bioorg Med Chem; 1995 Sep; 3(9):1273-80. PubMed ID: 8564420
[TBL] [Abstract][Full Text] [Related]
33. Solution structure of alpha-conotoxin MI determined by 1H-NMR spectroscopy and molecular dynamics simulation with the explicit solvent water.
Gouda H; Yamazaki K; Hasegawa J; Kobayashi Y; Nishiuchi Y; Sakakibara S; Hirono S
Biochim Biophys Acta; 1997 Dec; 1343(2):327-34. PubMed ID: 9434122
[TBL] [Abstract][Full Text] [Related]
34. NMR and computer-aided modeling studies of the interactions between a cyclic hexapeptide and the two enantiomers of some Boc- and Fmoc-amino acids.
McEwen I
Biopolymers; 1993 Jun; 33(6):933-42. PubMed ID: 8318666
[TBL] [Abstract][Full Text] [Related]
35. Beta-alanine containing peptides: a novel molecular tool for the design of gamma-turns.
Pavone V; Lombardi A; D'Auria G; Saviano M; Nastri F; Paolillo L; Di Blasio B; Pedone C
Biopolymers; 1992 Feb; 32(2):173-83. PubMed ID: 1637991
[TBL] [Abstract][Full Text] [Related]
36. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements.
De Luca S; Ragone R; Bracco C; Digilio G; Aloj L; Tesauro D; Saviano M; Pedone C; Morelli G
Chembiochem; 2003 Nov; 4(11):1176-87. PubMed ID: 14613109
[TBL] [Abstract][Full Text] [Related]
37. 1H nuclear magnetic resonance study of the solution conformation of an antibacterial protein, sapecin.
Hanzawa H; Shimada I; Kuzuhara T; Komano H; Kohda D; Inagaki F; Natori S; Arata Y
FEBS Lett; 1990 Sep; 269(2):413-20. PubMed ID: 2401368
[TBL] [Abstract][Full Text] [Related]
38. Solution structure of a cyclic RGD peptide that inhibits platelet aggregation.
Jois SD; Tambunan US; Chakrabarti S; Siahaan TJ
J Biomol Struct Dyn; 1996 Aug; 14(1):1-11. PubMed ID: 8877556
[TBL] [Abstract][Full Text] [Related]
39. Impact of a micellar environment on the conformations of two cyclic pentapeptides.
Bruch MD; Rizo J; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1741-54. PubMed ID: 1472656
[TBL] [Abstract][Full Text] [Related]
40. 1H NMR assignments of sidechain conformations in proteins using a high-dimensional potential in the simulated annealing calculations.
Habazettl J; Cieslar C; Oschkinat H; Holak TA
FEBS Lett; 1990 Jul; 268(1):141-5. PubMed ID: 2384151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
